SecBot SecBot
8-K ·Filed May 13, 2026

PVLA

PALVELLA THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001193125-26-220607
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for any subsequent filings that may indicate why the company pursued this upgrade (e.g., upcoming capital markets activity or institutional investor requirements). No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$120.57
T+0 close · May 13, 2026 · via day close
Latest settled
+30.85%
T+60 · $157.77
Vs SPY
+26.42%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 13 $120.57entry
  2. T+1 · 6mo ago −1.33%α −2.10% · $118.97
  3. T+5 · 6mo ago −9.43%α −8.27% · $109.20
  4. T+20 · 5mo ago −11.77%α −11.16% · $106.38
  5. T+60 · 3mo ago +30.85%α +26.42% · $157.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Palvella Therapeutics received approval from Nasdaq to transfer its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13, 2026. The ticker symbol PVLA remains unchanged. This is an administrative listing upgrade with no financial impact.

Key Facts

  • Nasdaq approved transfer from Capital Market to Global Market on May 11, 2026
  • Transfer effective at open of business on May 13, 2026
  • Ticker symbol PVLA unchanged

Financial Impact

No financial figures disclosed; administrative listing tier change only

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-220607
Document: 0001193125-26-220607-index-headers.html0001193125-26-220607
Document: 0001193125-26-220607-index.html0001193125-26-220607
Document: 0001193125-26-220607.txt0001193125-26-220607

Track record

36 reports on PVLA

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +35.07% at T+60 after the May 15, 2026 report. 8 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $145.21 Now $144.60 −0.42% settles Dec 16
  2. Nov 10, 20266d ago 144 Neutral 5/10 Entry $163.94 Now $144.60 −11.80% settles Dec 10
  3. Nov 5, 202611d ago 8-K Bullish 7/10 Entry $156.85 Now $144.60 −7.81% settles Dec 4
  4. Nov 5, 202611d ago Press Release Neutral 6/10 No price data
  5. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $152.93 Now $144.60 −5.45% settles Dec 2
  6. Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
  7. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
  8. Oct 28, 202619d ago Press Release Bullish 7/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
  9. Oct 23, 202624d ago Insider Cluster Neutral 2/10 Entry $126.23 Now $144.60 +14.55% settles Nov 23
  10. Oct 15, 20264w ago Press Release Neutral 4/10 Entry $127.34 to $153.18 Now $144.60 +13.55% ▲ +20.29% +22.19% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026